Sort
172,184 grants matching “inflammation”
Cell-free assay technologies for the identification of active compounds
$872,042Barry Okeefe · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Defining Vascular Functions of Proteoglycans through Chemical Biology Approaches
$872,000Kuberan Balagurunathan · Virginia Commonwealth University · P01 · FY2011 · HL
Basic and Clinical Studies of Cystic Fibrosis
$871,998Raymond A Frizzell · University Of Pittsburgh At Pittsburgh · P30 · FY2008 · DK
Basic and Clinical Studies of Cystic Fibrosis
$871,998Raymond A Frizzell · University Of Pittsburgh At Pittsburgh · P30 · FY2009 · DK
Pilot Project Core
$871,994Chandan Guha · Albert Einstein College Of Medicine · U19 · FY2013 · AI
COLLABORATIVE STUDY ON THE GENETICS OF ASTHMA
$871,913Wake Forest University Health Sciences · U01 · FY2000 · HL
Development of PAR2 Inhibitors for the Treatment of Nonalcoholic steatohepatitis
$871,604Athan Kuliopulos · Oasis Pharmaceuticals · R42 · FY2014 · DK
HIV Proteomic Center for Host-Viral Response Characterization
$871,487Richard D Smith · Battelle Pacific Northwest Laboratories · P01 · FY2008 · DA
Microbial Impact on NeuroDegeneration in Alzheimer's Dementia: MIND-AD
$871,255Adam Peter Spira · Johns Hopkins University · R01 · FY2022 · AG
Role of transposon dysregulation in Alzheimer and aging brains revealed by single-cell genomic and transcriptomic analysis
$871,185Eunjung Alice Lee · Boston Children'S Hospital · R01 · FY2023 · AG
A Novel Small Molecule for the Prevention and Treatment of Diabetic Retinopathy
$871,180Henry Younghwa Shin · Excitant Therapeutics, Llc · R44 · FY2022 · EY
Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids
$871,147Pietro P Sanna · Scripps Research Institute, The · R01 · FY2022 · DA
Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids
$871,147Pietro P Sanna · Scripps Research Institute, The · R01 · FY2021 · DA
Project 1: MiCAPP - Mechanisms of the CentrAlized Pain Phenotype
$871,137Daniel J Clauw · University Of Michigan At Ann Arbor · P50 · FY2020 · AR
Diagnosis of MIS-C in febrile children
$871,132Audrey Ragan Odom John · Children'S Hosp Of Philadelphia · R61 · FY2022 · HD
Chronic Kidney Disease in Children (CKiD)
$871,126Susan L Furth · Children'S Hosp Of Philadelphia · U01 · FY2012 · DK
âOverlapping and Discrete Pathways Through Which Prenatal Isolation and Uncertainty Stress Impact Maternal Mental Health and Child Neurodevelopment
$871,099Moriah E Thomason · New York University School Of Medicine · R01 · FY2021 · MH
Fibrinolytic therapies for methyl isocyanate
$871,068Carl W White · University Of Colorado Denver · U54 · FY2018 · ES
The Role of Stem Cells and the Microenvironment in Gastrointestinal Cancers
$871,044Timothy Cragin Wang · Columbia University Health Sciences · R35 · FY2021 · CA
Development of PAR2 Inhibitors for the Treatment of Nonalcoholic steatohepatitis
$871,014Athan Kuliopulos · Oasis Pharmaceuticals · R42 · FY2015 · DK
Modulation of Viral Antigen Presentation in the Lung
$870,979Anna Karolina Palucka · Jackson Laboratory · U19 · FY2023 · AI
Signal and Transcription Factor Network interactions in Head and Neck Cancer
$870,939Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZIA · FY2013 · DC
NF-kappaB in pathogenesis and therapy of head and neck cancer
$870,939Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZIA · FY2013 · DC
AD/ADRD and biological aging proteomic signatures in the etiopathology of delirium and its associated long-term cognitive decline
$870,666Edward R Marcantonio · Beth Israel Deaconess Medical Center · R01 · FY2024 · AG
Phase 2 Clinical Trial Evaluating a Novel Therapy in Patients who are Post-lung Transplant
$870,601Daniel W. Copeland · Renovion, Inc. · R44 · FY2021 · HL